share_log

Barrington Research Maintains Outperform on HealthEquity, Maintains $105 Price Target

Benzinga ·  Sep 20 23:11  · Ratings

Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and maintains $105 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment